-
AMAG Pharmaceuticals & Takeda Pharmaceutical Company Announce Strategic Collaboration for FerahemeAMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited recently announced they have entered into a license, development, and commercialization agreement related to Feraheme (feru2010/4/6
-
ISP Presents the Principles of Biodegradability at Offshore West AfricaWayne, NJ USA 30 March 2010 – At the Offshore West Africa conference in Accra, Ghana, ISP presented its findings on a new polymeric composite proven to degrade 60% or more within 28 days. Th2010/4/2
-
Evonik announces price increaseEffective April 1, 2010, or as contract terms allow, Evonik Industries’ Household Care Business Line will increase the prices for all products marketed in Europe in the range of 10 %. These price incr2010/4/2
-
SciClone Announces Topline Results From Phase 2 Clinical Trial of SCV-07 for Prevention of Oral MucositisStudy Shows Signal of Delay to Onset of Severe OM in Higher Dose Group SciClone Pharmaceuticals, Inc. announced topline results from the company's phase 2 clinical trial of SCV-07 for the preventio2010/4/2
-
Irritable Bowel Syndrome —Clinical Evaluation of Products for Treatment20100301(3).rar source: web of FDA2010/4/1
-
Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug PackagesGuidance for Industry - Final Guidance Printer-Friendly Version (PDF - 50 KB)1 Additional copies are available from:Office of Training and CommunicationsDivision of Drug Information, WO51, Room 22012010/4/1
-
SFDA strengthens supervision to oxygen supplies for medicineSFDA strengthens supervision to oxygen supplies for medicine In order to further strengthen the supervision to oxygen supplies for medicine, the State Food and Drug Administrati2010/4/1
-
PAT and Quality by Design for Biopharmaceuticals 2010Venue: CCT at Smithfield, London Description: Developing an in-house strategy for PAT and QbD application specifically for biopharmaceutical products Pharma IQ is delighted to announce the inaugural P2010/3/31
-
Celerion Acquires Early Stage Clinical Research Operations from MDS Pharma ServicesLife Sciences Industry Veteran Susan Thornton, Ph.D., Leads Privately Owned Contract Research Organization Celerion Celerion, a privately owned contract research organization (CRO), has completed t2010/3/31
-
Porsolt & Partners Pharmacology to Present Expertise in Preclinical In Vivo Studies at Bio 2010 in ChicagoPorsolt & Partners Pharmacology will be at BIO 2010 in Chicago this May to inform its sponsors and potential clients of the company's latest developments and research. The French contract research2010/3/31